Product Brochure

Your Product Innovation Begins Here: Booth 3G84

Overview

/Suppliers/Effepharm-Ltd — This year’s Vitafoods EU, EffePharm will showcase innovative anti-aging solutions, featuring Uthever® NMN, the world’s first large-scale, human clinically-proven NMN brand. Uthever® is pioneering the EU NOVEL FOOD application as the first NMN brand entering the risk assessment stage and is pending approval.

Also discover science-backed ingredient delivery technologies for enhanced bioavailability and functionality, featuring LipoAvail® liposomal NAD+ and liposomal Glutathione.

Download the product brochure to learn more about Uthever® NMN and check the scientific data for liposomal technology.

This content is provided by Effepharm Ltd, and any views and opinions expressed do not necessarily reflect those of NutraIngredients.com

Download Now

Latest Content

NMN supplementation proved to mitigate radiotherapy-induced damages

Paid for and content provided by Effepharm Ltd

Scientific study validates NMN’s efficacy in alleviating intestinal damages caused by radiotherapy through reducing alterations to gut bacteria composition and function.

NMN New Clinical Finding: Obvious NAD(H) Level Increase

Paid for and content provided by Effepharm Ltd

With 7.3% CAGR, The "Nicotinamide Mononucleotide (NMN) Market" size is expected to grow from 194.2 million USD In 2020, to reach 296.5 Million USD by 2026.”

Related Resources

Uthever® NMN NOVEL FOOD Update Download Whitepaper

13-Mar-2025

Content provided by Effepharm Ltd

White Paper

NMN is a precursor to NAD+. NAD+ is crucial for energy production, DNA repair, and regulating various cellular processes.

13X Boost in Glutathione with LipoAvail™

06-Sep-2024

Content provided by Effepharm Ltd

Product Brochure

Glutathione is a powerful antioxidant and vital metabolic regulator within cells. But it is unstable, susceptible to light, humidity, heat, gastric acid, and degrading enzymes.

Supplier Info Centre

For more product information visit Effepharm Ltd.